NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

As a follow-up to that post, and anyone reading this should read the post to which I’ve responded. Dr. Malik was appointed to the Board of NWBO in 2012.

In 2011, he was rated quite highly…

“Navid has over fifteen years' experience within the Pharmaceutical arena and is highly regarded in the Life Sciences equity research sector. He was awarded two StarMine Analyst Awards in 2011, having been ranked as the number one stock picker in the European Pharmaceuticals sector and number two stock picker in the UK and Ireland Healthcare sector.”

https://in.marketscreener.com/quote/stock/MERCHANT-SECURITIES-GROUP-4006497/news/Merchant-Securities-Group-PLC-12-09-2011-Analyst-Appointment-13793644/


Here is what Fidelity says about StarMine, Thompson Reuters statistical services rating equities and generally:

“About StarMine
StarMine is a division of Thomson Reuters focused primarily on building quantitative factor models for institutional investors. StarMine's equity analytics and research management tools help investment firms around the globe generate alpha and process equity information more efficiently. They are one of the largest and most trusted sources of objective equity research performance scores. Their performance scoring helps investors anticipate trends in analyst sentiment, predict surprises, evaluate financial statements for measures of earnings quality, and more.”

Leveraging the ignorance of people who read bulletin boards and are not professionals seems to be the main focus of really bad short traders who goose their results by fomenting.